DWTX:NASDAQ, Dogwood Therapeutics, Inc.

DWTX stock overview

Dogwood Therapeutics, Inc. (DWTX:NASDAQ) closed at $1.25 on October 15, 2026, down 0.79% on the day. The stock trades 82.3% below its 52-week high of $7.04 and 5.8% above its 52-week low of $1.18. Over the past year, it lost 79.2%. Dogwood Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$1.25
Day change
-0.79%
Volume
100,391
Average volume
66,168
Market cap
42M+
52-week range
$1.18 – $7.04
50-day average
$1.86
200-day average
$2.11

Performance

5D 1M 3M 6M 1Y
-8.76% -26.47% -9.42% -21.88% -79.20%

Price action over the past year

In 252 trading sessions since October 15, 2025, DWTX closed higher on 113 days (45%). Its best day was March 31, 2026 (+18.54%) and its worst was December 22, 2025 (-24.96%). The stock moved 10% or more in a single session 16 times.

Recent signals

DWTX news

About Dogwood Therapeutics, Inc.

Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia.

Similar stocks

Find more stocks like DWTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.